首页> 美国卫生研究院文献>other >Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S
【2h】

Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S

机译:在美国男同性恋和双性恋者的全国样本中对口服和长效可注射的HIV暴露前预防(PrEP)的了解和偏好

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We sought to determine preferences for oral versus long-acting injectable (LAI) PrEP among gay and bisexual men (GBM). We surveyed a national U.S. sample of 1071 GBM about forms of PrEP. LAI PrEP was found to be acceptable among 43.2 % of men when injected monthly compared with 53.6 % of men when injected every 3 months. When asked to choose between forms of PrEP, 46.0 % preferred LAI, 14.3 % oral, 21.7 % whichever was most effective, 10.1 % had no preference, and 7.8 % would not take PrEP. There were no differences in PrEP preferences by race/ethnicity, income, region of residence, or relationship status. Those unwilling to take PrEP were significantly older than those who preferred LAI PrEP and those who would take either. Those who preferred the most effective form were younger, had less education, and reported more recent club drug use. Those who reported condomless anal sex and those who thought they were good PrEP candidates were more willing to take PrEP. Long-term health and side effects were of the greatest concern for both LAI and oral PrEP. The availability of LAI PrEP has the potential to increase uptake among GBM. The results of ongoing clinical trials of LAI PrEP will need to demonstrate similar or greater efficacy as daily Truvada for uptake to be maximized.
机译:我们试图确定男同性恋者和双性恋男人(GBM)对口服或长效注射(LAI)PrEP的偏好。我们调查了1071 GBM的美国全国样本,了解PrEP的形式。发现每月注射LAI PrEP在男性的43.2%中是可以接受的,而每3个月注射的LAI PrEP在男性中为53.6%。当要求您选择PrEP的形式时,首选LAI为46.0%,口服为14.3%,最有效的为21.7%,10.1%没有优先选择,7.8%的患者不服用PrEP。 PrEP偏好在种族/民族,收入,居住地区或关系状况方面没有差异。那些不愿意服用PrEP的人比那些愿意接受LAI PrEP的人和那些愿意服用PrEP的人要大得多。那些更喜欢最有效形式的人是年轻的,受过较少的教育并且报告了最近使用俱乐部毒品的人。那些报告无避孕套肛交的人和那些认为自己是良好的PrEP候选人的人更愿意服用PrEP。对于LAI和口服PrEP而言,长期健康和副作用是最令人关注的问题。 LAI PrEP的可用性有可能增加GBM的吸收。 LAI PrEP正在进行的临床试验结果将需要证明与每日Truvada相似或更高的疗效,以最大程度地吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号